Warfarin loading dose guided by pharmacogenetics is effective and safe in cardioembolic stroke patients – a randomized, prospective study-Reference-Cited by-同舟云学术

Warfarin loading dose guided by pharmacogenetics is effective and safe in cardioembolic stroke patients – a randomized, prospective study

Published:2019-01-16 Issue:5 Volume:19 Page:446-454
ISSN:1470-269X
Container-title:The Pharmacogenomics Journal
language:en
Short-container-title:Pharmacogenomics J

Author:

Ruzickova Tereza,Sramek Martin,Kaplan Vojtech,Kumstyrova Simona,Lacinova Zuzana,Jansky Petr,Magerova Hana,Sarbochova Ivana,Schwabova Jaroslava Paulasova,Matoska Vaclav,Tomek Ales

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,Genetics,Molecular Medicine

Link

http://www.nature.com/articles/s41397-019-0066-4.pdf

Reference37 articles.

1. Landefeld CS, Goldman L. Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy. Am J Med. 1989;87:144–52.

2. O’Reilly RA, Aggeler PM. Studies on coumarin anticoagulant drugs: initiation of warfarin without a loading dose. Circulation. 1968;38:169–77.

3. Harrison L, Johnston M, Massicotte P, Crowther M, Moffat K, Hirsh J. Comparison of 5-ing and 10-mg loading doses in initiation of warfarin therapy. Ann Intem Med. 1997;126:133–6.

4. Crowther MA, Ginsberg JB, Kearon C, Harrison L, Johnson J, Massicotte MP, et al. A randomized trial comparing 5-mg and 10-mg warfarin loading doses. Arch Intern Med. 1999;159:46–48.

5. Kovacs MJ, Roger M, Anderson DR, Morrow B, Kells G, Kovacs J, et al. Comparison of 10-mg and 5-mg warfarin initiation nomograms together with low-molecular-weight heparin for outpatient treatment of acute venous thromboembolism. A randomized, double-blind, controlled trial. Ann Intern Med. 2003;138:714–9.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The investigation of connection between anticoagulant therapy and vitamin K homologues in human determined by LC–MS/MS;Bioanalysis;2024-08-14

2. Molecular diagnostics for coagulopathies;Diagnostic Molecular Pathology;2024

3. Hyper-responsiveness to warfarin in a young patient with the VKORC1 -1639GA/CYP2C9*1*46 genotype: a case report;Thrombosis Journal;2022-10-27

4. Genetic Associations With Stable Warfarin Dose Requirements in Han Chinese Patients;Journal of Cardiovascular Pharmacology;2021-07

5. Considerations When Applying Pharmacogenomics to Your Practice;Mayo Clinic Proceedings;2021-01